These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28368584)

  • 21. The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.
    Thomas JB; Giddings AM; Olepu S; Wiethe RW; Warner KR; Sarret P; Longpre JM; Runyon SP; Gilmour BP
    Bioorg Med Chem Lett; 2015; 25(10):2060-4. PubMed ID: 25881832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.
    Fanelli R; Besserer-Offroy É; René A; Côté J; Tétreault P; Collerette-Tremblay J; Longpré JM; Leduc R; Martinez J; Sarret P; Cavelier F
    J Med Chem; 2015 Oct; 58(19):7785-95. PubMed ID: 26348111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
    Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
    Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.
    Perron A; Sharif N; Sarret P; Stroh T; Beaudet A
    Biochem Biophys Res Commun; 2007 Feb; 353(3):582-90. PubMed ID: 17188644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NT79: A novel neurotensin analog with selective behavioral effects.
    Boules M; Liang Y; Briody S; Miura T; Fauq I; Oliveros A; Wilson M; Khaniyev S; Williams K; Li Z; Qi Y; Katovich M; Richelson E
    Brain Res; 2010 Jan; 1308():35-46. PubMed ID: 19874804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand.
    Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR
    Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.
    Lee MR; Hinton DJ; Unal SS; Richelson E; Choi DS
    Alcohol Clin Exp Res; 2011 Jan; 35(1):99-107. PubMed ID: 21039631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based evolution of subtype-selective neurotensin receptor ligands.
    Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
    ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
    Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
    Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
    Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
    Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
    Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
    Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
    Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
    Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.
    Sarret P; Esdaile MJ; Perron A; Martinez J; Stroh T; Beaudet A
    J Neurosci; 2005 Sep; 25(36):8188-96. PubMed ID: 16148226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells.
    Sarret P; Gendron L; Kilian P; Nguyen HM; Gallo-Payet N; Payet MD; Beaudet A
    J Biol Chem; 2002 Sep; 277(39):36233-43. PubMed ID: 12084713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.
    Lundquist JT; Dix TA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2579-82. PubMed ID: 10498212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of NTS2 receptors in stress-induced analgesia.
    Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
    Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
    Souazé F; Forgez P
    Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
    Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
    J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
    Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
    Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.